Cantor Fitzgerald Forecasts Onto Innovation FY2025 Earnings
Equities researchers at Cantor Fitzgerald dropped their FY2025 earnings per share (EPS) estimates for shares of Onto ...
Tariff hawks eager to see de minimis rule shuttered after Trump pause
President Trump pumped the brakes last week on a pledge to shut down an import tax exemption for cheap consumer goods from ...
Cantor Fitzgerald maintains Overweight on ORIC stock
Cantor Fitzgerald reiterated its Overweight rating on ORIC Pharmaceuticals (NASDAQ:ORIC), currently trading at $13.39, after an incident involving a potential news leak. According to InvestingPro data ...
Economy will remain strong for months to come, says Cantor Fitzgerald's Eric Johnston
Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for equity markets, what will have a powerful impact on equities, and much more.
Science Applications International (NYSE:SAIC) Research Coverage Started at Cantor Fitzgerald
Cantor Fitzgerald started coverage on shares of Science Applications International (NYSE:SAIC – Free Report) in a research ...
ORIC Pharmaceuticals shares surge on potential data leak
ORIC Pharmaceuticals Inc. (NASDAQ: ORIC) shares rose 12% following a recommendation from Cantor Fitzgerald to buy shares amid a possible leak of encouraging clinical trial data. Analyst Prakhar ...